What is Phlow?
Phlow operates as a modern contract development and manufacturing organization (CDMO) that bridges the gap between laboratory innovation and large-scale commercial production. By leveraging advanced technology and a mission-driven approach, the firm provides comprehensive solutions for both government and private sector partners. Its core value proposition lies in its ability to reduce waste and accelerate time-to-market for vital pharmaceutical products, thereby fostering healthier and more resilient communities. As a B Corporation, Phlow integrates social and environmental performance into its business model, setting a new standard for how medicines are developed and manufactured in the United States.
How much funding has Phlow raised?
Phlow has raised a total of $107M across 4 funding rounds:
Unspecified
$15M
Series A
$20M
Series B
$35M
Series C
$37M
Unspecified (2020): $15M, investors not publicly disclosed
Series A (2021): $20M, investors not publicly disclosed
Series B (2023): $35M, investors not publicly disclosed
Series C (2025): $37M featuring Align Private Capital
Key Investors in Phlow
Align Private Capital
Align Private Capital is a women-owned, SEC-registered investment advisor that specializes in alternative investing for Single Family Offices, focusing on direct investment opportunities with strong risk-adjusted returns.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Phlow?
With the successful closure of its latest financing round, Phlow is well-positioned to accelerate its strategic initiatives. The capital will likely be deployed to expand its world-class manufacturing capabilities and further integrate its tech-enabled processes into the broader pharmaceutical ecosystem. As the industry faces increasing pressure to localize production and mitigate supply chain vulnerabilities, Phlow's focus on domestic drug substance development remains a critical differentiator. Future growth will likely center on scaling operations to meet rising demand while maintaining the high standards of quality and sustainability that define the company's market identity. Investors are closely watching how this infusion of capital will translate into increased market share and long-term operational efficiency.
See full Phlow company page
